In addition, we found that sEVs released by RT/TMZ treated GBM cells contained elevated levels of proteins known to drive invadopodia initiation, including the EV surface proteins fascin and MMP14 that were absent in sEVs secreted from untreated MU4 cells. The gene discussed is MMP14; the disease is glioblastoma.